Ruwen Jou

Prof. Ruwen Jou


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
WHWei-Lun Huang
Wei-Lun Huang
HCHuang-Yau Chen
Huang-Yau Chen
YKYuh-Min Kuo
Yuh-Min Kuo
RJRuwen Jou
Ruwen Jou
To facilitate the management of multidrug-resistant (MDR) tuberculosis, two nucleic acid sequence-based methods, the GenoType MTBDR plus test and DNA sequencing, were assessed for the rapid detection of drug-resistant Mycobacterium tuberculosis for the first time in the Asia-Pacific region. The performances of these two assays in detecting the presence of rifampin (rifampicin) (RIF) and isoniazid (INH) resistance-associated mutations in the rpoB , katG , inhA regulatory region, inhA , and oxyR-ahpC genes were compared to that of a conventional agar proportion drug susceptibility test. A total of 242 MDR and 30 pansusceptible M. tuberculosis isolates were evaluated in this study. The sensitivities obtained for RIF-resistant detection by the GenoType MTBDR plus test and by resistance gene sequencing were 95.5% and 97.9%, respectively. The sensitivities for INH resistance detection by the GenoType MTBDR plus test and by resistance gene sequencing were 81.8% and 93.4%, respectively. Together, the sensitivity for MDR tuberculosis detection was 78.5% with the GenoType MTBDR plus test and 91.3% by resistance gene sequencing. The specificity for RIF resistance, INH resistance, and MDR detection was 100% by both methods. The GenoType MTBDR plus test has the advantage of a short turnaround time for drug-resistant M. tuberculosis detection. Overall, the two assays performed equally well in detecting RIF resistance ( P = 0.13). However, DNA sequencing demonstrated superior performance in detecting INH resistance ( P < 0.001) and MDR tuberculosis ( P < 0.001). We suggest that new alleles of INH resistance genes should be evaluated to improve the sensitivity of the GenoType MTBDR plus test, especially for different geographic areas with genetically diverse M. tuberculosis strains.

1 July 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
WHWEI-LUN Huang
WEI-LUN Huang
TCTing-Lin Chi
Ting-Lin Chi
MWMei-Hua Wu
Mei-Hua Wu
RJRuwen Jou
Ruwen Jou
The GenoType MTBDRsltest and DNA sequencing were used to rapidly detect second-line drug- and ethambutol (EMB)-resistantMycobacterium tuberculosis. The ability of these two assays to detect the presence of mutations associated with resistance to fluoroquinolones (FLQ), aminoglycosides/cyclic peptide (AG/CP), and EMB in thegyrA,rrs, andembBgenes (for the GenoType MTBDRsltest) andgyrA,gyrB,rrs,eis,embC,embA,embB, andembRgenes (for DNA sequencing) was compared to that of conventional agar proportion drug susceptibility testing (DST). We evaluated 234 multidrug-resistant (MDR)M. tuberculosisisolates. The two molecular methods had high levels of specificity (95.8 to 100%). The sensitivities for FLQ resistance detection for both methods were 85.1%. For AG (kanamycin [KM] and amikacin [AM]) and CP (capreomycin CAP]), the sensitivities of resistance detection using the GenoType MTBDRsltest were 43.2%, 84.2%, and 71.4%, respectively, while with the inclusion of an extra gene,eis, in sequencing, the sensitivity reached 70.3% for detection of KM resistance. The sensitivities of EMB resistance detection were 56.2% and 90.7% with the GenoType MTBDRsltest and sequencing, respectively. We found that the GenoType MTBDRsltest can rapidly detect resistance to FLQ, CAP, and AM. The accuracy of the GenoType MTBDRsltest for the detection of FLQ and AM resistance was comparable to that of conventional DST; however, the test was less accurate for the detection of KM and EMB resistance and demonstrated a poor predictive value for CAP resistance. We recommend including new alleles consisting of theeispromoter andembBgenes in molecular analysis. However, conventional DST is necessary to rule out false-negative results from molecular assays.

19 January 2022 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
KKKoné Kaniga
Koné Kaniga
RHRumina Hasan
Rumina Hasan
RJRuwen Jou
Ruwen Jou
EVEdita Vasiliauskienė
Edita Vasiliauskienė
CCCharoen Chuchottaworn
Charoen Chuchottaworn
SOShaheed Vally Omar
Shaheed Vally Omar
Bedaquiline drug resistance emergence assessment in multidrug-resistant-tuberculosis (MDR-TB) (DREAM) was a 5-year (2015 to 2019) phenotypic drug resistance surveillance study across 11 countries. DREAM assessed the susceptibility of 5,036 MDR-TB isolates of bedaquiline treatment-naive patients to bedaquiline and other antituberculosis drugs by the 7H9 broth microdilution (BMD) and 7H10/7H11 agar dilution (AD) MIC methods.

21 December 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
SWSheng-Han Wu
Sheng-Han Wu
YXYu-Xin Xiao
Yu-Xin Xiao
HHHseuh-Chien Hsiao
Hseuh-Chien Hsiao
RJRuwen Jou
Ruwen Jou
We developed and validated a tNGS assay that was the first to target 22 whole genes instead of regions of drug resistance genes and comprehensively detected susceptibility to 14 anti-TB drugs, with great flexibility to include new or repurposed drugs. Notably, we demonstrated that our custom-designed Ion AmpliSeq TB research panel platform had high concordance with pDST and could significantly reduce turnaround time (by approximately 70%) to meet a clinically actionable time frame.

1 March 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
MYMing-Chih Yu
Ming-Chih Yu
HCHuang-Yao Chen
Huang-Yao Chen
MWMei-Hua Wu
Mei-Hua Wu
WHWei-Lun Huang
Wei-Lun Huang
YKYuh-Min Kuo
Yuh-Min Kuo
RJRuwen Jou
Ruwen Jou
A culture confirmation test for the detection of Mycobacterium tuberculosis complex strains that uses a lateral-flow immunochromatographic assay to detect the MPB64 antigen, the MGIT TBc identification (TBc ID) test, has been developed. We evaluated the performance of the TBc ID test in the detection of the M. tuberculosis complex in 222 primary-positive liquid cultures. We compared these results to those of nucleic acid-based identification and conventional biochemical tests. The validity of the TBc ID test was determined, and all of the nontuberculous mycobacteria (NTM) and Nocardia species tested were found to be negative. The detection limit of the TBc ID test was 5 × 10 5 CFU/ml, and for IS 6110 real-time PCR it was 5 CFU/ml. All of the M. tuberculosis and M. africanum cultures were found to be positive, while M. bovis and M. bovis BCG cultures were negative. With the exception of 1 contaminated culture, the 221 culture-positive isolates contained 171 (77.5%) M. tuberculosis isolates, 39 (17.6%) NTM species, and 11 (5.0%) unidentified species. Two culture-positive isolates harbored a 63-bp deletion at position 196 of the mpb64 gene. The sensitivity, specificity, positive predictive values, and negative predictive values of the TBc ID test were 98.8, 100, 100, and 95.1%, respectively. Furthermore, the approximate turnaround time for real-time PCR was 4 h (including buffer and sample preparation), while for the TBc ID test it was less than 1 h. We suggest an algorithm for the primary identification of M. tuberculosis in liquid culture using the TBc ID test as an alternative to conventional subculture followed by identification using biochemical methods.

1 January 2005 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
RJRuwen Jou
Ruwen Jou
CCChen-Yuan Chiang
Chen-Yuan Chiang
WHWei-Lun Huang
Wei-Lun Huang
To investigate the distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan, we collected 421 M. tuberculosis complex clinical isolates at random from four geographic regions of Taiwan and analyzed them by spacer oligonucleotide typing (spoligotyping) in 2003. We found 113 resolved spoligotypes, among which we identified 28 (24.8%) clusters. One hundred eighty-seven (44.4%) isolates were Beijing family genotypes and consisted of 172 (40.9%) characteristic Beijing genotypes and 15 (3.6%) Beijing-like ones. We also found that substantially larger proportions of tuberculosis patients were infected with Beijing family genotypes in the northern (51.6%) and eastern (46.2%) regions of Taiwan, while 31.6 and 28.0% of the tuberculosis patients in the central and southern regions, respectively, were infected with these genotypes. The proportion of Beijing genotype isolates was the highest in patients below the age of 24 years (61.5%), the second highest in elderly patients over age 65 years (46.8%), and the lowest in middle-age patients between the ages of 45 and 54 years (34.0%). Geographic location and age were found by multivariate analysis to be associated with Beijing family genotypes. Antituberculosis drug resistance was found more often in Beijing family genotype strains (46.4%) than in non-Beijing family genotype strains (34.3%), with more Beijing family genotype strains being resistant to ethambutol and isoniazid. These findings suggest that M. tuberculosis Beijing family genotypes have been dominant for several decades and that they are the cause of a significant proportion of the recent transmissions of tuberculosis in Taiwan.